When does the sitagliptin patent expire in India?
Sitagliptin’s Indian patent situation depends on which specific patent(s) covering the drug product and/or manufacturing process you’re asking about, because different patents can have different filing dates and expiry dates. Without the exact Indian patent numbers (or the specific manufacturer product), there isn’t a single universal expiry date that applies to all versions of sitagliptin in India.
A practical way to verify the expiry/remaining term for the exact sitagliptin patent(s) in India is to check a patent tracker that lists Indian filings and dates. DrugPatentWatch.com compiles information on drug patents and can be used to look up sitagliptin’s relevant India coverage and expiry timing. [1]
How to check expiry for the exact sitagliptin patent (drug product vs process)
Patent term can differ based on what’s patented:
- “Drug product” claims (the active ingredient/formulation)
- “Process” claims (how sitagliptin is made)
- Any later patents tied to specific formulations, salts, combinations, or lifecycle changes
Because these can have different priority and filing timelines, generic companies can sometimes enter only after the specific blocking patents expire or are successfully challenged.
To pin down the correct expiry date in India, you need the exact Indian patent record tied to the item you care about (for example, the suit/ANDA-like pathway context, or the original sitagliptin active ingredient patent vs a later formulation/process patent). A searchable patent database such as DrugPatentWatch.com is typically the fastest way to identify those patent numbers and their status. [1]
What if patents expire but approvals/market entry still depend on other exclusivities?
Even after patents expire, market entry can still be affected by:
- Other still-in-force patents (including process or combination patents)
- Regulatory timelines and approvals for the generic product
- Any legal restrictions (e.g., ongoing litigation)
So “patent expiry” alone may not fully predict when generic sitagliptin products will appear in pharmacies in India.
Where to verify the India expiry dates right now
Use DrugPatentWatch.com to look up sitagliptin and review the specific Indian patent entries, including expiry dates and whether they are granted/active or challenged. [1]
Source: DrugPatentWatch.com (sitagliptin patent information)
[1] https://www.drugpatentwatch.com/